DD204266A5 - Verfahren zur herstellung von lymphoblastoiden interferonen - Google Patents

Verfahren zur herstellung von lymphoblastoiden interferonen Download PDF

Info

Publication number
DD204266A5
DD204266A5 DD82243742A DD24374282A DD204266A5 DD 204266 A5 DD204266 A5 DD 204266A5 DD 82243742 A DD82243742 A DD 82243742A DD 24374282 A DD24374282 A DD 24374282A DD 204266 A5 DD204266 A5 DD 204266A5
Authority
DD
German Democratic Republic
Prior art keywords
leu
ser
glu
asp
ala
Prior art date
Application number
DD82243742A
Other languages
German (de)
English (en)
Inventor
Francois Meyer
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27261323&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD204266(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of DD204266A5 publication Critical patent/DD204266A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DD82243742A 1981-10-03 1982-10-01 Verfahren zur herstellung von lymphoblastoiden interferonen DD204266A5 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8129937 1981-10-03
GB8208988 1982-03-26
GB08224871A GB2108510B (en) 1981-10-03 1982-09-01 Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof

Publications (1)

Publication Number Publication Date
DD204266A5 true DD204266A5 (de) 1983-11-23

Family

ID=27261323

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82243742A DD204266A5 (de) 1981-10-03 1982-10-01 Verfahren zur herstellung von lymphoblastoiden interferonen

Country Status (19)

Country Link
US (1) US5089400A (da)
EP (1) EP0076489B1 (da)
JP (2) JPH06104066B2 (da)
KR (1) KR920007665B1 (da)
AU (1) AU561104B2 (da)
DD (1) DD204266A5 (da)
DE (1) DE3280174D1 (da)
DK (1) DK170714B1 (da)
ES (2) ES516154A0 (da)
FI (1) FI80719C (da)
GB (1) GB2108510B (da)
GR (1) GR76992B (da)
HU (1) HU197047B (da)
IE (1) IE54051B1 (da)
IL (1) IL66920A0 (da)
NO (1) NO166494C (da)
NZ (1) NZ202058A (da)
PH (2) PH21524A (da)
PT (1) PT75643B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
DE3220116A1 (de) 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
CA1271717A (en) * 1982-10-11 1990-07-17 National Biological Standards Board Polypeptides useful in vaccination against enteroviruses
IE56509B1 (en) * 1982-11-04 1991-08-28 Univ California Methods for oncogenic detection
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
JPS6156199A (ja) * 1984-08-27 1986-03-20 Shionogi & Co Ltd 新規ヒトインタ−フエロンα類
DE3685044D1 (de) * 1985-02-01 1992-06-04 Ici Plc Analoge interferon-polypeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
ATE81675T1 (de) * 1985-04-30 1992-11-15 Takeda Chemical Industries Ltd Produktion eines proteins.
EP0205404B1 (en) * 1985-06-11 1992-07-15 Ciba-Geigy Ag Hybrid interferons
ATE125304T1 (de) 1986-04-15 1995-08-15 Ciba Geigy Ag Monoklonale antikörper gegen interferon- induziertes humanes protein in gereignigter form, und diese antikörper enthaltende testsätze.
TW218846B (da) * 1992-04-07 1994-01-11 Ciba Geigy
US5834202A (en) * 1992-08-04 1998-11-10 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
US5733733A (en) * 1992-08-04 1998-03-31 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
WO1994003624A1 (en) * 1992-08-04 1994-02-17 Auerbach Jeffrey I Methods for the isothermal amplification of nucleic acid molecules
US6261808B1 (en) 1992-08-04 2001-07-17 Replicon, Inc. Amplification of nucleic acid molecules via circular replicons
US20020102236A1 (en) * 1994-12-08 2002-08-01 Taylor Peter William Liposomal interferon hybrid compositions
DK0801682T3 (da) 1995-02-09 2002-02-18 Aventis Pharma Gmbh Fremgangsmåde til fremstilling af proteiner
US6087102A (en) * 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
US6685933B1 (en) 1998-07-28 2004-02-03 The United States Of America As Represented By The Department Of Health And Human Services Interferon α hybrids
DE19919149A1 (de) * 1999-04-27 2000-11-16 Wieser Raimund J Von Interferon alpha-2 abgeleitete Peptid-Homodimere und Peptid-Heterodimere
WO2002036627A2 (en) * 2000-11-03 2002-05-10 Pbl Biomedical Laboratories Interferons, uses and compositions related thereto
WO2002088161A1 (en) * 2001-05-02 2002-11-07 Pepgen Corporation Method for expression of human interferon alpha 1 in pichia pa storis
FR2825716B1 (fr) 2001-06-11 2004-09-24 Genodyssee Nouveaux polynucleotides et polypeptides de l'ifn alpha 7
EA013263B1 (ru) * 2004-12-20 2010-04-30 Кадила Хелзкэр Лимитед Способ получения интерферона-бета
US20190071589A1 (en) 2016-11-21 2019-03-07 Nitto Denko Corporation Pressure-sensitive adhesive sheet
US20190077999A1 (en) 2016-11-21 2019-03-14 Nitto Denko Corporation Pressure-sensitive adhesive sheet

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA796175B (en) * 1978-11-24 1980-11-26 Hoffmann La Roche Purified proteins and process therefor
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
NZ195980A (en) * 1980-01-08 1984-10-19 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing leukocyte interferon-like polypeptides;pharmaceutical and veterinary compositions
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
JP2687995B2 (ja) * 1980-04-03 1997-12-08 バイオゲン インコーポレイテッド Ｄｎａ配列、組替えｄｎａ分子およびヒト繊維芽細胞インターフェロン様ポリペプチドの製造方法
EP0042246B1 (en) * 1980-06-12 1987-03-18 The Cancer Institute Of Japanese Foundation For Cancer Research Plasmid
ES8302778A1 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof

Also Published As

Publication number Publication date
PT75643A (en) 1982-11-01
EP0076489B1 (de) 1990-05-16
FI823356A0 (fi) 1982-10-01
NZ202058A (en) 1986-05-09
IE822385L (en) 1983-04-30
FI80719B (fi) 1990-03-30
JPS5890596A (ja) 1983-05-30
GB2108510B (en) 1984-12-12
US5089400A (en) 1992-02-18
GR76992B (da) 1984-09-04
AU561104B2 (en) 1987-04-30
KR840002031A (ko) 1984-06-11
GB2108510A (en) 1983-05-18
NO166494C (no) 1991-08-07
PH23119A (en) 1989-05-05
EP0076489A3 (en) 1984-03-28
NO823314L (no) 1983-04-05
JPH07173195A (ja) 1995-07-11
AU8895882A (en) 1983-04-14
IL66920A0 (en) 1982-12-31
EP0076489A2 (de) 1983-04-13
PT75643B (en) 1986-11-13
NO166494B (no) 1991-04-22
FI823356L (fi) 1983-04-04
IE54051B1 (en) 1989-05-24
KR920007665B1 (ko) 1992-09-14
DK437382A (da) 1983-04-04
ES8504936A1 (es) 1985-04-16
ES516154A0 (es) 1985-04-16
DE3280174D1 (de) 1990-06-21
PH21524A (en) 1987-11-16
DK170714B1 (da) 1995-12-18
ES8601237A1 (es) 1985-11-01
FI80719C (fi) 1990-07-10
JPH06104066B2 (ja) 1994-12-21
HU197047B (en) 1989-02-28
ES528141A0 (es) 1985-11-01
JP2612149B2 (ja) 1997-05-21

Similar Documents

Publication Publication Date Title
EP0076489B1 (de) Desoxyribonucleinsäuren, rekombinante Desoxyribonucleinsäuren, sie enthaltende Wirte, Polypeptide und Verfahren zu ihrer Herstellung
DE3382771T2 (de) Ein Gamma-Interferon kodierendes synthetisches Gen.
DE3177288T2 (de) Reife menschliche leukozyten-interferone, verfahren zu ihrer bacteriellen herstellung, zwischenprodukte hierfuer und zusammensetzungen diese enthaltend.
DE3685996T2 (de) Hybrid-interferone.
DE3220116C2 (da)
US4853332A (en) Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
EP0218825A1 (en) Cysteine-depleted muteins of interferon-beta, their preparation, formulations containing them, and structural genes, vectors and organisms, and their production, suitable for use in the preparation of said muteins
DD159782A5 (de) Verfahren zur herstellung eines eine immunologische oder biologische aktivitaet von humanleukozyten-interferon aufweisendes polypeptids
EP0161504B1 (de) Herstellung von Polypeptiden mit Human-Gammainterferon-Aktivität
DD209477A5 (de) Verfahren zur herstellung von mikroorganismen
DD212748A5 (de) Verfahren zur bildung doppelstraengiger, hybride human-leukozyten-interferone kodierender dns
HU193512B (en) Process for preparing hybride interferones from human erythrocytes
DE3144469A1 (de) Hybride human-leukozyten-interferone
DD160280A5 (de) Verfahren zur herstellung eines eine immunologische oder biologische aktivitaet von humanfibroblast-interferon aufweisenden polypeptids
DD202046A5 (de) Verfahren zur herstellung eines chimeren proteins
DE3781217T2 (de) Herstellung von verwandten polypeptiden des bindungsfaktors.
EP0115613B1 (de) DNA-Sequenzen, deren Herstellung, diese Sequenzen enthaltende Plasmide und deren Verwendung zur Synthese eukaryotischer Genprodukte in Prokaryoten
DD219212A5 (de) Verfahren zur herstellung eines rekombinanten dna-klonierungsvektors
US4695543A (en) Alpha Interferon GX-1
DE3103714A1 (de) Dns-rekombinationsverfahren zur herstellung eines dem menschlichen interferon aehnlichen proteins
DE3490055T1 (de) Menschliches Leukozyteninterferon N und Verfahren zu dessen Herstellung in Bakterienzellen
AT394208B (de) Verfahren zur herstelluung von vektoren
AT394207B (de) Verfahren zur herstellung von human-leukozyteninterferonen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee